BIO-RAD LABORATORIES, INC. — Director's Dealing 2019

Sep 13, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO, BIOB)
CIK: 0000012208
Period of Report: 2019-09-12

Reporting Person: HERTIA JOHN (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-09-12	Bio-Rad A Common Stock	M	600	$119.54	Acquired	18966	Direct
2019-09-12	Bio-Rad A Common Stock	M	600	$139.56	Acquired	19566	Direct
2019-09-12	Bio-Rad A Common Stock	S	797	$328.25	Disposed	18769	Direct
2019-09-12	Bio-Rad A Common Stock	S	41	$329.00	Disposed	18728	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-09-12	Non-Qualified Stock Option (right to buy)	$119.54	M	600	Disposed	2024-09-10	Bio-Rad A Common Stock (600)	Direct
2019-09-12	Non-Qualified Stock Option (right to buy)	$139.56	M	600	Disposed	2025-09-11	Bio-Rad A Common Stock (600)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Bio-Rad A Common Stock	252	Indirect

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $328.00 to $328.70, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2: The option vests in five equal annual installments beginning September 10, 2015.

F3: The option vests in five equal annual installments beginning September 11, 2016.